Ryan N. Henderson

Array ( [id] => 4964837 [patent_doc_number] => 20080107657 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-08 [patent_title] => 'ANTIBODIES THAT BIND TO AN EPITOPE ON THE HUNTINGTON\'S DISEASE PROTEIN' [patent_app_type] => utility [patent_app_number] => 11/849851 [patent_app_country] => US [patent_app_date] => 2007-09-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 16508 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0107/20080107657.pdf [firstpage_image] =>[orig_patent_app_number] => 11849851 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4889522 [patent_doc_number] => 20080263687 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-23 [patent_title] => 'CHIMERIC RETINOID X RECEPTORS AND THEIR USE IN A NOVEL ECDYSONE RECEPTOR-BASED INDUCIBLE GENE EXPRESSION SYSTEM' [patent_app_type] => utility [patent_app_number] => 11/841648 [patent_app_country] => US [patent_app_date] => 2007-08-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 30157 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 22 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0263/20080263687.pdf [firstpage_image] =>[orig_patent_app_number] => 11841648 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4735803 [patent_doc_number] => 20080052785 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-02-28 [patent_title] => 'ANIMAL MODEL OF CHOLINERGIC DYSFUNCTION TO EVALUATE COGNITIVE ENHANCERS AND DRUGS THAT IMPROVE MYASTHENIA' [patent_app_type] => utility [patent_app_number] => 11/842406 [patent_app_country] => US [patent_app_date] => 2007-08-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 15184 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0052/20080052785.pdf [firstpage_image] =>[orig_patent_app_number] => 11842406 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4432647 [patent_doc_number] => 07968691 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-06-28 [patent_title] => 'Pullulanase variants with increased productivity' [patent_app_type] => utility [patent_app_number] => 11/841526 [patent_app_country] => US [patent_app_date] => 2007-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 12 [patent_no_of_words] => 12070 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/968/07968691.pdf [firstpage_image] =>[orig_patent_app_number] => 11841526 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8328460 [patent_doc_number] => 08236556 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-08-07 [patent_title] => 'Method of modulating gene expression using an ecdysone receptor-based inducible gene expression system' [patent_app_type] => utility [patent_app_number] => 11/841597 [patent_app_country] => US [patent_app_date] => 2007-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 13 [patent_no_of_words] => 30289 [patent_no_of_claims] => 49 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 272 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11841597 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9875044 [patent_doc_number] => 08962311 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-02-24 [patent_title] => 'Method of obtaining chicken embryonic stem cells' [patent_app_type] => utility [patent_app_number] => 12/376660 [patent_app_country] => US [patent_app_date] => 2007-08-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 13922 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 107 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12376660 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4657598 [patent_doc_number] => 20080026459 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-01-31 [patent_title] => 'ISOLATION, SELECTION AND PROPAGATION OF ANIMAL TRANSGENIC STEM CELLS' [patent_app_type] => utility [patent_app_number] => 11/832165 [patent_app_country] => US [patent_app_date] => 2007-08-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 6385 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0026/20080026459.pdf [firstpage_image] =>[orig_patent_app_number] => 11832165 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4825801 [patent_doc_number] => 20080124792 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-29 [patent_title] => 'Hybrid promoters' [patent_app_type] => utility [patent_app_number] => 11/880838 [patent_app_country] => US [patent_app_date] => 2007-07-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 29 [patent_no_of_words] => 14613 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0124/20080124792.pdf [firstpage_image] =>[orig_patent_app_number] => 11880838 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4909232 [patent_doc_number] => 20080019998 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-01-24 [patent_title] => 'TARGETED GENE DELIVERY FOR DENDRITIC CELL VACCINATION' [patent_app_type] => utility [patent_app_number] => 11/781865 [patent_app_country] => US [patent_app_date] => 2007-07-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 30829 [patent_no_of_claims] => 56 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0019/20080019998.pdf [firstpage_image] =>[orig_patent_app_number] => 11781865 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6638346 [patent_doc_number] => 20100035973 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-11 [patent_title] => 'DISRUPTION OF PROGRAMMED DEATH 1 (PD-1) LIGAND TO ADJUVANT ADENO-ASSOCIATED VIRUS VECTOR VACCINES' [patent_app_type] => utility [patent_app_number] => 12/373880 [patent_app_country] => US [patent_app_date] => 2007-07-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12755 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0035/20100035973.pdf [firstpage_image] =>[orig_patent_app_number] => 12373880 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6386463 [patent_doc_number] => 20100077491 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-25 [patent_title] => 'Modulators of RNF5 and Uses Thereof' [patent_app_type] => utility [patent_app_number] => 12/373314 [patent_app_country] => US [patent_app_date] => 2007-07-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 27395 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0077/20100077491.pdf [firstpage_image] =>[orig_patent_app_number] => 12373314 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8870890 [patent_doc_number] => 08466267 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-06-18 [patent_title] => 'Nucleic acid encoding a zinc finger that recognizes the sodium channel Nav 1.8 (PN3) gene' [patent_app_type] => utility [patent_app_number] => 11/825655 [patent_app_country] => US [patent_app_date] => 2007-07-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 8 [patent_no_of_words] => 28792 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 71 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11825655 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 361840 [patent_doc_number] => 07481179 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-01-27 [patent_title] => 'In ovo activation of an egg in the shell' [patent_app_type] => utility [patent_app_number] => 11/824229 [patent_app_country] => US [patent_app_date] => 2007-06-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12950 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 81 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/481/07481179.pdf [firstpage_image] =>[orig_patent_app_number] => 11824229 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5355602 [patent_doc_number] => 20090186946 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-23 [patent_title] => 'Genetically Modified Animal and Use Thereof' [patent_app_type] => utility [patent_app_number] => 12/306480 [patent_app_country] => US [patent_app_date] => 2007-06-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 18382 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0186/20090186946.pdf [firstpage_image] =>[orig_patent_app_number] => 12306480 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4654071 [patent_doc_number] => 20080022931 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-01-31 [patent_title] => 'Methods for Injecting Avian Eggs' [patent_app_type] => utility [patent_app_number] => 11/768046 [patent_app_country] => US [patent_app_date] => 2007-06-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 16984 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0022/20080022931.pdf [firstpage_image] =>[orig_patent_app_number] => 11768046 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5434933 [patent_doc_number] => 20090169519 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-02 [patent_title] => 'MEDICINAL FORMULATION CONTAINING A COMBINATION OF HIV TYPE I AND HIV TYPE II' [patent_app_type] => utility [patent_app_number] => 12/296876 [patent_app_country] => US [patent_app_date] => 2007-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6647 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0169/20090169519.pdf [firstpage_image] =>[orig_patent_app_number] => 12296876 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6339455 [patent_doc_number] => 20100199367 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-05 [patent_title] => 'MANGANESE SUPEROXIDE DISMUTASE EXON 3-DELETED ISOFORMS AND NUCLEIC ACID MOLECULES ENCODING THE ISOFORMS' [patent_app_type] => utility [patent_app_number] => 11/757685 [patent_app_country] => US [patent_app_date] => 2007-06-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 12276 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0199/20100199367.pdf [firstpage_image] =>[orig_patent_app_number] => 11757685 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4869620 [patent_doc_number] => 20080148416 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-06-19 [patent_title] => 'TRANSGENIC ANIMALS FOR ASSESSING DRUG METABOLISM AND TOXICITY' [patent_app_type] => utility [patent_app_number] => 11/757972 [patent_app_country] => US [patent_app_date] => 2007-06-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 85 [patent_figures_cnt] => 85 [patent_no_of_words] => 34685 [patent_no_of_claims] => 99 [patent_no_of_ind_claims] => 40 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0148/20080148416.pdf [firstpage_image] =>[orig_patent_app_number] => 11757972 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4771880 [patent_doc_number] => 20080057538 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-03-06 [patent_title] => 'Chaperone expression genomes' [patent_app_type] => utility [patent_app_number] => 11/810386 [patent_app_country] => US [patent_app_date] => 2007-06-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 21371 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0057/20080057538.pdf [firstpage_image] =>[orig_patent_app_number] => 11810386 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5473004 [patent_doc_number] => 20090246170 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-01 [patent_title] => 'Therapeutic Agent For Alzheimer\'s Disease' [patent_app_type] => utility [patent_app_number] => 12/302927 [patent_app_country] => US [patent_app_date] => 2007-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 18789 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0246/20090246170.pdf [firstpage_image] =>[orig_patent_app_number] => 12302927 [rel_patent_id] =>[rel_patent_doc_number] =>)